Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 3446-3455, December 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belman, S.
Right arrow Articles by Troll, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belman, S.
Right arrow Articles by Troll, W.

Phorbol-12-myristate-13-acetate Effect on Cyclic Adenosine 3',5'-Monophosphate Levels in Mouse Skin and Inhibition of Phorbol-myristate-acetate-promoted Tumorigenesis by Theophylline1

Sidney Belman and Walter Troll

Department of Environmental Medicine, New York University Medical Center, New York, New York 10016

The most effective tumor-promoting agent, phorbol-myristate-acetate, lowers cyclic adenosine 3'5'-monophosphate levels in mouse skin. A decrease is seen 1 hr after treatment; at 2 hr, a minimum is reached and maintained for 24 hr. At 48 hr, the cyclic adenosine 3',5'-monophosphate level rises to control or greater values. Theophylline inhibits phorbol-myristate-acetate-promoted tumorigenesis. It appears that a decrease in cyclic adenosine 3',5'-monophosphate levels is related to tumor promotion.

1 This investigation was supported by project grants from the NIH (USPHS Research Grants ES-00505 and CA-08621) and a grant from the Allied Chemical Corporation and is part of a Center Program by the National Institute of Environmental Health Sciences Grant ES-00260. This work was previously reported (4).

Received 3/ 2/74. Accepted 8/27/74.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
E. A. Rogozin, K. W. Lee, N. J. Kang, H. Yu, M. Nomura, K.-I. Miyamoto, A. H. Conney, A. M. Bode, and Z. Dong
Inhibitory effects of caffeine analogues on neoplastic transformation: structure-activity relationship
Carcinogenesis, June 1, 2008; 29(6): 1228 - 1234.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.